Note that some links may require registration or subscription. The United Kingdom's Food Standards Agency says that certain ...

A retrospective study presented at the recent American Society of Clinical Oncology (ASCO) meeting suggested that patients ...

In the DESTINY-Breast09 trial, presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, first-line trastuzumab deruxtecan (T-DXd; Enhertu) combined with pertuzumab ...

The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn.

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...

The study cohort had a median age around 60, with about 20% women and a median BMI of 26. Nearly 80% were white and the rest ...

Physicians and medical students pressed the AMA to commit to a more urgent and advocacy-focused approach to supporting their ...

Six of the patients, of whom four had non-renal SLE, had follow-up of at least 24 weeks. Of those, five showed dramatic ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

CHICAGO -- Bobby Mukkamala, MD, credits NIH-funded research for the targeted therapy that keeps his brain tumor at bay. But ...